4
Changes in Ownership
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-26-101671
Chief Strategy Officer sold 1,897 shares at $10.78 ($20,450)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nayak Sanjay Chief Strategy Officer | 2026-08-24 | Sale 10b5-1 | −1,897 | $10.78 | $20,450 | 326,898 | D |
| Open-market sales · 1,897 sh · avg $10.78 · $20,450 | |||||||
Loading xslF345X06/tm2624096-3_4seq1.xml…